• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·9273.T
Share

Koa Shoji Holdings Co.,Ltd. Stocks

¥ 780Last Updated 22.07.2026

Issuer Rating

5/7
Performance

Strong

Risk

Moderate

Recommendation

Hold

Market Cap

¥ 197.44M

¥ 780
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Koa Shoji Holdings Co.,Ltd., established in 1991 and headquartered in Yokohama, Japan, operates through its subsidiaries, engaging in a diverse array of pharmaceutical activities. The company sources and distributes active pharmaceutical ingredients and their precursors throughout the Japanese market. Additionally, it is involved in the production and commercialization of a range of injectable medications, alongside over-the-counter drugs, with a particular emphasis on vitamin formulations. Koa Shoji Holdings also manufactures and distributes generic pharmaceuticals. Complementing these operations, the firm provides outsourced drug production services and offers specialized packaging solutions for medicinal products.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.07.2026 09:00

Analysts have recommended buying Ralph Lauren stock. They see potential in the EU and China

22.07.2026 08:00

A Chinese AI startup that has impressed the market is aiming for a $50 billion valuation ahead of its IPO

22.07.2026 05:26

Short sellers have taken positions against nearly a third of SpaceX's outstanding shares. Should we expect a sell-off?

22.07.2026 03:53

iPhone Rentals: Apple to Launch a Lease Program for Its Devices — Bloomberg

22.07.2026 02:49

Nvidia claimed that its new Vera processor outperforms AMD's competing product

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026